Oligonucleotide Aptamer-Mediated Precision Therapy of Hematological Malignancies

Precision medicine has recently emerged as a promising strategy for cancer therapy because it not only specifically targets cancer cells but it also does not have adverse effects on normal cells. Oligonucleotide aptamers are a class of small molecule ligands that can specifically bind to their targe...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shuanghui, Li, Huan, Xu, Ling, Deng, Zhenhan, Han, Wei, Liu, Yanting, Jiang, Wenqi, Zu, Youli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172475/
https://www.ncbi.nlm.nih.gov/pubmed/30292138
http://dx.doi.org/10.1016/j.omtn.2018.08.023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172475/
https://www.ncbi.nlm.nih.gov/pubmed/30292138
http://dx.doi.org/10.1016/j.omtn.2018.08.023

Ejemplares similares